Monday, June 30, 2014

Celerion expands in to Asia and finds partners for success

This year, Celerion, they bring their expertise in early stage clinical trials and bioanalysis while the KDDF will profit by working with a company who can bring their Korean drug discoveries to a global market.
Celerion has put an emphasis on taking their clinical research to Asia and finding partners in the local regions for success. Earlier this year, Celerion expanded in to South Korea with a partnership with Korean Drug Development Fund (KDDF) which unites government, industry and academia. In this partnership, according to

To continue their focus on Asian expansion, earlier this month, Celerion also announced their expansion in to Singapore.  The country - which has a very centralized location between India, Japan and Australia, the company has started by hiring Chew Lan Chong, a veteran of more than 130 early studies sponsored by the likes of Pfizer ($PFE) and Eli Lilly ($LLY), to serve as executive director and lead its new outpost.  According to FierceCRO, the company will join forces with expertise in pharmacogenetics and ethnic bridging studies. The country is taking measures to invest in biotech, the demand is high and Celerion has joined Covance, Parexel and others in the region for conducing clinical trials.

This September in Shanghai, the Partnerships in Clinical Trials Asia conference will bring together experts from across the field to spend an afternoon focusing on optimizing clinical relationships and collaboration.  In the session Innovative Approaches to Clinical Partnering, an interactive panel will feature representatives from Sanofi, Roche, Merck and Beigene to discuss determining pros and cons of partnering with local vs. global SMOs & CROs, maintaining relationship and generating good quality supporting protocols and more.  Find out more about this session by downloading the agenda.  If you'd like to join us this fall in Shanghai, as a reader of this blog, when you register to join us and mention code XP1975BLOG, you can save 20% off the standard rate.

No comments: